MEDP Medpace Holdings, Inc.
$677.56▼ -2.18%
Healthcare
Other
After hours
$677.56▲ +0.00%
Oct 29, 4:00 PM ET
Volume 250.3K
Avg Volume (10D) 440.0K
Key Metrics & Fundamentals
Market Cap
$18.95B
P/E Ratio
37.6
Div Yield
0.00%
52W Range
373.00 - 693.97
% vs 50 MA
9.58%
% vs 200 MA
28.04%
RSI-14
64.8
MACD Histogram
+5.9500
Beta (1Y vs SPY)
0.65
Free Cash Flow
$196.44M
Gross Rev
$716.00M
Gross Profit
$223.89M
EBITDA
$172.12M
COGS
$492.12M
Operating Exp
$58.35M
Operating Income
$165.54M
EBIT
$165.54M
Pretax Income
$170.91M
Net Income
$137.46M
EPS (Diluted)
4.84
Price & Volume History
Loading chart…
Recent News
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
Zacks · Oct 29, 2026 8:15 AM ET
Medpace Holdings Insider Sold Shares Worth $13,540,000, According to a Recent SEC Filing
MT Newswires · Oct 28, 2026 4:29 PM ET
Breakout Watch: 4 Reasons To Monitor This Top-Rated Medical Stock
Investor's Business Daily · Oct 28, 2026 3:13 PM ET
BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down
Zacks · Oct 28, 2026 11:20 AM ET
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks · Oct 26, 2026 11:45 AM ET
All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy
Zacks · Oct 26, 2026 11:00 AM ET
MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues
StockStory · Oct 23, 2026 7:20 PM ET
Medpace's Bookings, Pre-Backlog Trends Support Growth Outlook, UBS Says
MT Newswires · Oct 23, 2026 2:42 PM ET
UBS Adjusts Price Target on Medpace to $700 From $673, Maintains Neutral Rating
MT Newswires · Oct 23, 2026 9:40 AM ET
Dow Jones Futures Fall After Moderna Crashes, Meta Fuels AI Meltdown. Warren Buffett Market Is Thriving.
Investor's Business Daily · Oct 23, 2026 8:14 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2026
See MEDP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.